Clinical Trials Directory

Trials / Unknown

UnknownNCT04361578

Magnetic Resonance Elastography in Patients With Acute Closed Traumatic Brain Injury

Prediction of Short-term Outcome in Patients With Acute Closed Traumatic Brain Injury Using Magnetic Resonance Elastography

Status
Unknown
Phase
Study type
Observational
Enrollment
43 (estimated)
Sponsor
Xiangya Hospital of Central South University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Traumatic brain injury (TBI) is a major public health issue, and intracranial hypertension in the acute phase remains a critical scientific issue. Many patients with acute closed TBI received conservative, non-surgical treatments at first, while 5%\~19% of which develops intractable intracranial hypertension that requires emergent surgery. Therefore, it is of great clinical significance to identify patients who are at high risk of deterioration in the early stage. Previous studies have found that brain compliance is a contributive factor to intracranial pressure, and might serve in the development of intracranial hypertension after TBI. We made assumption that intracranial pressure has a negative relationship with brain compliance providing that the volume of hematoma remains constant. However, few studies have applied magnetic resonance elastography (MRE) in evaluating brain compliance in patients with TBI. Therefore, this study is designed to enroll patients with acute closed traumatic brain injury who are initially treated non-surgically. Magnetic resonance elastography (MRE) sequences are performed to non-invasively assess patients' brain compliances, in the hope of exploring the potential value of MRE biomarkers to predict the short-term outcome in patients with acute closed TBI who are initially receive non-surgical treatments.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMagnetic resonance elastographyAll patients enrolled will receive magnetic resonance elastography of the brain.

Timeline

Start date
2020-09-01
Primary completion
2021-07-31
Completion
2021-08-31
First posted
2020-04-24
Last updated
2020-07-07

Source: ClinicalTrials.gov record NCT04361578. Inclusion in this directory is not an endorsement.